Moderna Inc (MRNA) surged +16.35 on Friday, getting the benefit of the negative news about vaccine rival AstraZeneca. After facing criticism about findings of the phase 3 trial of its vaccine developed in collaboration with Oxford University, CEO of AstraZeneca on Thursday said that further analysis of the vaccine was required.
Tesla Inc (TSLA) ended the week with a rise of 2.05%. The California-based electric cars pioneer, having worth more than $560 billion on Wall Street, said it plans to open an electric vehicle charger manufacturing facility in China in 2021 to raise its sales in the world’s largest automotive market. Furthermore, a formal inquiry into the potential suspension of 115,000 vehicles has been undertaken by the National Highway Traffic Safety Administration (NHTSA). In China, Tesla has also initiated the 870 Model X recall for a component fixing problem.
JD.com Inc (JD) rose 1.34 percent at close of the session on Friday. The launch of JD Health International in Hong Kong was a great success. The selling of JD Health shares have been oversubscribed 53.8 times, according to StreetAccount.
Teva Pharmaceutical Industries Limited (TEVA) gained 0.72 percent at weekend session. The European Commission has fined EUR 60.5 million to Israel’s giant specialty and generic drug maker. Owing to the delay in the marketing of a generic version of Cephalon’s sleep disorder drug, the fine applies to Teva and Cephalon, which is its subsidiary.
Amazon.com Inc (AMZN) was up 0.32 percent on Friday. The U.S. e-commerce company has revealed that in the light of the health crisis, it will spend more than $500 million in exceptional incentives for its workers remained mobilized during the holiday season.
Tiffany & Co (TIF) was up 0.11 percent at close of the trading on Friday. The New York-based jeweler will hold an online general meeting on 30 December to present to its shareholders the acquisition bid offered by LVMH, the French luxury giant.